Author

Lars Björn Riecken

Heidelberg UniversityORCID 0000-0002-1992-4591Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Scientific Communication & Education· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:differential expression· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Helen MorrisoniD· 2 shared Ana BanitoiD· 1 shared Anca Kliesow RemesiD· 1 shared André ScheragiD· 1 shared Andrea Matzen· 1 shared Anne‐Laure BoulesteixiD· 1 shared Arunabh SharmaiD· 1 shared Astrid DempfleiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersScientific Communication & Education

Helen MorrisonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multi-Lab Testing of Early Preclinical Discoveries Identifies Promising Treatments

Pasquale Pellegrini, Sophia C. Rotter, María Arroyo-Araujo, Clarissa F. D. Carneiro, Natascha Drude, Lorena Martinez‐Gamboa, Ana Banito, Nadine Rabe Bernhardt, Anne‐Laure Boulesteix, Frank Buttgereit, Astrid Dempfle, Nayar Durán-Hernández, Timo Gaber, Marcus Groettrup, Bettina Habelt, , Ulf Toelch

The paper evaluates multi-laboratory studies to identify promising treatments by assessing effect sizes and experimental rigor across different medical fields.

bioRxiv · Oct 30, 2026 · PreprintScientific Communication & Education

A Multicenter Confirmatory Randomized-Controlled Study of rhNRGβ1 Protein Replacement Therapy in a Murine Model of NF2-related Schwannomatosis

Michael Reuter, Susann Groth, Johanna Schleep, Lars Björn Riecken, Lisa Schindler, Marie Juliane Jung, Venkat Krishnan Sundaram, Emilio Cirri, Nadine Pömpner, Lisa Wedekind, Julia Palm, André Scherag, Ruth Martha Stassart, Robert Fledrich, Reinhard Bauer, Helen Morrison

Across three German sites and 207 analyzed mice, systemic rhNRGβ1 at 10 µg/kg did not reduce schwannoma nerve thickness or shift Schwann cell differentiation markers.

bioRxiv · Aug 4, 2026 · PreprintCancer Biology✦ In-depth digest